Elevance Health, Inc. (ELV)
NYSE: ELV · Real-Time Price · USD
382.16
-4.54 (-1.16%)
Feb 21, 2025, 10:14 AM EST - Market open
Elevance Health Analyst Ratings
Total Analysts
15
Consensus Rating
Buy
Price Target
$530.83
Upside
+38.90%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Argus Research | Argus Research | Hold Reiterates $405 | Hold | Reiterates | $405 | +6.08% | Jan 29, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $483 → $478 | Buy | Maintains | $483 → $478 | +25.08% | Jan 28, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $485 | Buy | Reiterates | $485 | +26.91% | Jan 24, 2025 |
| Barclays | Barclays | Buy Maintains $501 → $512 | Buy | Maintains | $501 → $512 | +33.98% | Jan 24, 2025 |
| Truist Securities | Truist Securities | Strong Buy Maintains $520 → $480 | Strong Buy | Maintains | $520 → $480 | +25.60% | Jan 6, 2025 |
| Mizuho | Mizuho | Buy Maintains $585 → $505 | Buy | Maintains | $585 → $505 | +32.14% | Nov 5, 2024 |
| Wells Fargo | Wells Fargo | Buy Maintains $593 → $495 | Buy | Maintains | $593 → $495 | +29.53% | Nov 4, 2024 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $643 → $551 | Buy | Maintains | $643 → $551 | +44.18% | Oct 23, 2024 |
| Barclays | Barclays | Buy Maintains $622 → $501 | Buy | Maintains | $622 → $501 | +31.10% | Oct 22, 2024 |
| TD Cowen | TD Cowen | Strong Buy Maintains $589 → $484 | Strong Buy | Maintains | $589 → $484 | +26.65% | Oct 21, 2024 |
| UBS | UBS | Strong Buy Maintains $605 → $555 | Strong Buy | Maintains | $605 → $555 | +45.23% | Oct 18, 2024 |
| Truist Securities | Truist Securities | Strong Buy Reiterates $620 → $520 | Strong Buy | Reiterates | $620 → $520 | +36.07% | Oct 18, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $585 → $478 | Buy | Maintains | $585 → $478 | +25.08% | Oct 18, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $600 → $485 | Buy | Maintains | $600 → $485 | +26.91% | Oct 18, 2024 |
| Barclays | Barclays | Buy Maintains $611 → $622 | Buy | Maintains | $611 → $622 | +62.76% | Oct 10, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $600 | Buy | Reiterates | $600 | +57.00% | Oct 1, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.